INVESTOR ALERT: Investigation of AbbVie Inc. Announced by The Wagner Firm

LOS ANGELES--()--The Wagner Firm announces that it is investigating potential claims on behalf of shareholders of AbbVie Inc. (“AbbVie” or the “Company”) (NYSE:ABBV). The investigation concerns possible breaches of fiduciary duties by the Company’s Board of Directors.

Specifically, the investigation relates to certain agreements made between AbbVie and the Board of Directors of Abbot Laboratories prior to the spinoff of AbbVie from Abbot Laboratories. If you currently hold AbbVie shares, have information or would like to learn more about this investigation, or if you wish to discuss your rights or interests with respect to these matters, please contact Avi Wagner, Esquire, of The Wagner Firm, 1925 Century Park East, Suite 2100, Los Angeles, California 90067, at (310) 491-7949, by e-mail at info@thewagnerfirm.com, or visit our website at http://thewagnerfirm.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

The Wagner Firm, Los Angeles, CA
Avi Wagner, 310-491-7949
info@thewagnerfirm.com
www.thewagnerfirm.com

Release Summary

Contact The Wagner Firm if you purchased shares of AbbVie Inc. and still hold those shares.

Sharing

Contacts

The Wagner Firm, Los Angeles, CA
Avi Wagner, 310-491-7949
info@thewagnerfirm.com
www.thewagnerfirm.com